Vulvovaginal Candidiasis. Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
Conditions
Interventions
Treatment - Drugs
Placebo
Fluconazole is a drug against fungi. In this study Each capsule contains: 150 mg, zahravi pharm.co.tabriz-iran. Each capsule contains: 150mg,single dose, on first and third day after beginning of trea
Sponsors
The International Branch of Shahid Beheshti University of Medical Sciences & Health Services
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:1-Married women aged 18-40 years 2-Having one partner 3-Absence of pregnancy and breast feeding 4-Absence of mensturation at the time of attendance 5-Useage of the clotrimazole for a temporary time and lack of improvement-6-Not using vaginal drug, antibiotics , immonosupressive drugs and exogenous hormones such as oral contraceptives since 2 weeks before starting the research 7-Not having intercourse or using vaginal douche within the last 24 hours 8-Absence of other types of trichmonas vaginitis and bacterial vaginosis at the time of study 9- Absence of any diagnose medical disease such as diabetis and other auto immune diseases , by asking a patient 10-Verification of vulvovaginal Candidiasis resalted clinical symptoms and KOH positive examples and cultivation. Exclusion criteria: 1-Allergic reactions of fluconazole and protexin 2-Pregnancy during therapy 3-Compulsion to use antibiotics or other anti fungous medicines 4-The menses 5-Usage of vaginal douche during treatment 6-Sexual intercourse without condoms during treatment.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volvovaginitis Candidiasis. Timepoint: At the time of presentation and 5-7 days after treatment. Method of measurement: Observation- Sabouraud dextrose agar medium. | — |
Secondary
| Measure | Time frame |
|---|---|
| Volvovaginitis Candidiasis treatment. Timepoint: 5-7 days after treatment. Method of measurement: Observations-Sabouraud dextrose agar medium. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoheila Nouraei
The International Branch of Shahid Beheshti University of Medical Sciences & Health Services
Outcome results
None listed